Sabinsa Corporation   Report issue

For profit Phase 1 Phase 2
Founded: East Windsor NJ United States (1988)
Status: No NME R&D (1988)

Organization Overview

First Clinical Trial
2004
NCT00094445
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now